The following documents have been filed with the SEC:
SEC Filing Alert
10-Q: Quarterly report pursuant to Section 13 or 15(d)
HTML
PDF
If you have any questions, or would like to contact Investor Relations, please reply to this email.
Aurinia Pharmaceuticals Inc.#1203-4464 Markham Street, Victoria, BC V8Z 7X8 Canada
https://www.auriniapharma.com